Opendata, web and dolomites

METABONE SIGNED

A new approach of metastatic bone fracture prediction using a patient-specific model including metastatic tissue, daily-life activities and local failure criteria

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 METABONE project word cloud

Explore the words cloud of the METABONE project. It provides you a very rough idea of what is the project "METABONE" about.

medullar    tumoral    huge    guide    economic    accurate    metastases    finite    limited    estimate    experimental    patients    qct    hypothesised    successful    loading    human    diseased    severely    prediction    stance    clinical    completion    mechanical    sensitivity    metabone    local    ex    locomotor    scans    influential    located    simulations    tool    surgery    qualitative    computed    bone    clinicians    significantly    strategy    fracture    strength    decision    femoral    alter    femur    lack    responsible    compression    restricted    tomography    mobility    segments    determined    vivo    predict    first    clinically    made    fragility    models    patient    quality    model    evaluation    single    criteria    accuracy    material    combining    limitations    numerical    survival    hampered    composition    metastatic    proximal    quantitative    risk    daily    socio    global    tissue    life    efforts    oncology    optimize    osteolytic    lesions    specificity    scores    performed    prevent    experimentally    healthy    methodology   

Project "METABONE" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITE LYON 1 CLAUDE BERNARD 

Organization address
address: BOULEVARD DU 11 NOVEMBRE 1918 NUM43
city: VILLEURBANNE CEDEX
postcode: 69622
website: www.univ-Iyon1.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 184˙707 €
 EC max contribution 184˙707 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2019
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2020
 Duration (year-month-day) from 2020-04-01   to  2022-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITE LYON 1 CLAUDE BERNARD FR (VILLEURBANNE CEDEX) coordinator 184˙707.00

Map

 Project objective

Osteolytic bone metastases are responsible for long bone fracture leading to restricted mobility, surgery, or medullar compression that severely alter quality of life and have a huge socio-economic impact. Current fragility scores to estimate the fracture risk in patients with metastatic femur are based on qualitative evaluation from Quantitative Computed Tomography (QCT) scans and lack sensitivity and specificity. Efforts are now made towards the development of patient-specific finite element models to assess the strength of tumoral bone segments, but their accuracy is hampered by several limitations, including limited knowledge of metastatic bone mechanical properties, simulations performed only for single stance loading condition, and simulations providing a global failure criteria. The aim of METABONE is, therefore, to use a novel approach to better predict the fracture risk of metastatic femur. A patient-specific finite element model will be developed based on QCT scans, which will include the real material properties of ex vivo human metastatic bone determined experimentally in the first part of the project. The composition and mechanical behaviour of diseased bone tissue are hypothesised to be rather different from healthy tissue and influential of femoral strength. This model will be used clinically on patients with osteolytic lesions located in proximal femur to assess the fracture risk during daily life activities, using a local failure criteria and a range of different loading conditions. This novel methodology, combining experimental and numerical approaches, is expected to significantly improve the accuracy of fracture risk prediction. Successful completion of METABONE will have the potential to guide clinical decision making, by providing clinicians with a more accurate tool to optimize locomotor strategy and oncology program, in order to prevent bone fracture, improve survival and quality of life of the patients.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "METABONE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "METABONE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

EXPAND (2019)

Examining pan-neotropical diasporas

Read More  

CINEMA (2019)

Creating an Infrastructure for the Numerical Exploration of Metallurgical Alloys

Read More  

IRF4 Degradation (2019)

Using a novel protein degradation approach to uncover IRF4-regulated genes in plasma cells

Read More